TriSalus Life Sciences, Inc. ·
TLSIW 8-K 2026-09-22
TriSalus Life Sciences, Inc. (TLSIW) 8-K dated 2026-09-22 — accession 0001628280-26-063031. This URL is the filing, not the TLSIW hub.
TriSalus Life Sciences, Inc. (TLSIW) warrant listed on NASDAQ.
TriSalus Life Sciences, Inc. filed a 8-K on 2026-09-22. Accession 0001628280-26-063031.
Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported TLSIW revenue for 2025-12-31 was $45.2M. Net income was -$39.2M. Revenue was up 53.4% from 2024-12-31 to 2025-12-31.
Not investment advice. The TLSIW SEC hub lists recent forms. The stock page is the research view.